ZA98656B - Lage-1 tumer associated nucleic acids - Google Patents

Lage-1 tumer associated nucleic acids

Info

Publication number
ZA98656B
ZA98656B ZA98656A ZA98656A ZA98656B ZA 98656 B ZA98656 B ZA 98656B ZA 98656 A ZA98656 A ZA 98656A ZA 98656 A ZA98656 A ZA 98656A ZA 98656 B ZA98656 B ZA 98656B
Authority
ZA
South Africa
Prior art keywords
lage
tumer
nucleic acids
associated nucleic
fragments
Prior art date
Application number
ZA98656A
Other languages
English (en)
Inventor
Bernard Lethie
Sophie Lucas
Charles De Smet
Daniele Godelaine
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of ZA98656B publication Critical patent/ZA98656B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ZA98656A 1997-01-27 1998-01-27 Lage-1 tumer associated nucleic acids ZA98656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79149597A 1997-01-27 1997-01-27

Publications (1)

Publication Number Publication Date
ZA98656B true ZA98656B (en) 1998-08-17

Family

ID=25153920

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98656A ZA98656B (en) 1997-01-27 1998-01-27 Lage-1 tumer associated nucleic acids

Country Status (9)

Country Link
EP (2) EP0970206B1 (fr)
AT (1) ATE402259T1 (fr)
AU (1) AU6042198A (fr)
DE (1) DE69839765D1 (fr)
DK (1) DK0970206T3 (fr)
ES (1) ES2310418T3 (fr)
PT (1) PT970206E (fr)
WO (1) WO1998032855A1 (fr)
ZA (1) ZA98656B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021535B1 (fr) * 1997-10-08 2007-03-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Nouvel antigene du cancer humain ny eso-1/cag-3 et gene le codant
US7084239B1 (en) 1997-10-08 2006-08-01 The United States Of America As Represented By The Department Of Health And Human Services Cancer peptides of NY-ESO-1/CAG-3
EP1806403A3 (fr) * 1997-10-08 2008-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Nouvel antigène de cancer humain NY ESO 1/CAG-3 et gène codant pour celui-ci
AU766278B2 (en) * 1998-09-01 2003-10-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The PAGE-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
EP1001022A1 (fr) * 1998-10-16 2000-05-17 Boehringer Ingelheim International GmbH CAMEL, un produit de translation alternative d'antigène tumoraux LAGE-1
WO2006113540A2 (fr) 2005-04-14 2006-10-26 Duke University Utilisation d'un agent qui restaure l'irrigation et l'oxygenation des tissus
US8309096B2 (en) 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US844693A (en) 1906-03-21 1907-02-19 Otto Seidel Jr Portable leach-clearing apparatus.
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
GB9019812D0 (en) 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5405940A (en) 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
US5620886A (en) 1993-03-18 1997-04-15 Ludwig Institute For Cancer Research Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
US5571711A (en) 1993-06-17 1996-11-05 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
US5645829A (en) 1993-06-18 1997-07-08 Beth Israel Hospital Association Mesothelial cell gene therapy
US5610013A (en) 1993-07-22 1997-03-11 Ludwig Institute For Cancer Research Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
US5589334A (en) 1994-06-03 1996-12-31 Ludwig Institute For Cancer Research Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof
US5997870A (en) 1994-06-03 1999-12-07 Ludwig Institute For Cancer Research Isolated peptides which bind to HLA-B44 Molecules
US5830753A (en) 1994-09-30 1998-11-03 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
US5587289A (en) 1995-03-14 1996-12-24 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof
US5939526A (en) 1995-03-21 1999-08-17 Ludwig Institute For Cancer Research Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof
US5821122A (en) 1995-06-07 1998-10-13 Inserm (Institute Nat'l De La Sante Et De La Recherche . .) Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
US7947022B2 (en) 2005-03-04 2011-05-24 C. R. Bard, Inc. Access port identification systems and methods

Also Published As

Publication number Publication date
WO1998032855A1 (fr) 1998-07-30
DK0970206T3 (da) 2008-10-13
EP0970206A1 (fr) 2000-01-12
EP0970206B1 (fr) 2008-07-23
ATE402259T1 (de) 2008-08-15
EP1961820A3 (fr) 2008-12-24
ES2310418T3 (es) 2009-01-01
EP1961820A2 (fr) 2008-08-27
AU6042198A (en) 1998-08-18
EP1961820B1 (fr) 2012-11-28
PT970206E (pt) 2008-10-28
DE69839765D1 (de) 2008-09-04

Similar Documents

Publication Publication Date Title
WO1999053061A3 (fr) Acides nucleiques associes a des tumeurs et leur emploi
ZA988124B (en) Mage-3 peptides presented by HLA class II molecules
DE69434594D1 (de) Rekombinante adenoviren-vektor und verfahren zur verwendung
WO2000055318A3 (fr) Methodes et reactifs permettant de moduler les taux de cholesterol
PL299053A1 (en) Amino acid compound being a nucleic acid, vector, host cell, genomic zyme clone, method of diagnozing the alzheimer disease, method of determining and expressing a nucleic acid sequence
ATE394484T1 (de) Smad 6 und dessen anwendungen
WO2002095051A3 (fr) Peptides mage-a3 presentes par des molecules hla de classe ii
DE69635207D1 (de) Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
CY1107552T1 (el) Ly6h γονιδιο
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
ZA98656B (en) Lage-1 tumer associated nucleic acids
ATE214708T1 (de) Kationische mittel zur transfektion von nukleinsäuren
ZA902425B (en) Retinoblastoma gene product and uses therefor
ES2170082T3 (es) Transactivador de mhc clase ii (ciita) y sus usos.
WO1996038556A3 (fr) Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse
DE69519654D1 (de) htFIIIA Gen
AU5179596A (en) Method and means for the production of gene products, novel recombinant dna vectors therefor and kits employing them
AU6241296A (en) Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp)
AU6408196A (en) Genetic therapy employing the hhv-6a derived ts gene or polypeptide
EP1428833A3 (fr) 207 protéines humaines sécrétées